Climate, demography, immunology, and virology combine to drive two decades of dengue virus dynamics in Cambodia.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 Sep 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: ppublish

Résumé

The incidence of dengue virus disease has increased globally across the past half-century, with highest number of cases ever reported in 2019 and again in 2023. We analyzed climatological, epidemiological, and phylogenomic data to investigate drivers of two decades of dengue in Cambodia, an understudied endemic setting. Using epidemiological models fit to a 19-y dataset, we first demonstrate that climate-driven transmission alone is insufficient to explain three epidemics across the time series. We then use wavelet decomposition to highlight enhanced annual and multiannual synchronicity in dengue cycles between provinces in epidemic years, suggesting a role for climate in homogenizing dynamics across space and time. Assuming reported cases correspond to symptomatic secondary infections, we next use an age-structured catalytic model to estimate a declining force of infection for dengue through time, which elevates the mean age of reported cases in Cambodia. Reported cases in >70-y-old individuals in the 2019 epidemic are best explained when also allowing for waning multitypic immunity and repeat symptomatic infections in older patients. We support this work with phylogenetic analysis of 192 dengue virus (DENV) genomes that we sequenced between 2019 and 2022, which document emergence of DENV-2 Cosmopolitan Genotype-II into Cambodia. This lineage demonstrates phylogenetic homogeneity across wide geographic areas, consistent with invasion behavior and in contrast to high phylogenetic diversity exhibited by endemic DENV-1. Finally, we simulate an age-structured, mechanistic model of dengue dynamics to demonstrate how expansion of an antigenically distinct lineage that evades preexisting multitypic immunity effectively reproduces the older-age infections witnessed in our data.

Identifiants

pubmed: 39190356
doi: 10.1073/pnas.2318704121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2318704121

Subventions

Organisme : Bill and Melinda Gates Foundation (GF)
ID : OPP1211806
Organisme : Bill and Melinda Gates Foundation (GF)
ID : OPP1211841
Organisme : Chan Zuckerberg Biohub
ID : NA

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Cara E Brook (CE)

Department of Ecology and Evolution, University of Chicago, Chicago, IL 60637.

Carly Rozins (C)

Department of Science, Technology, and Society, York University, Toronto, ON M3J 1P3, Canada.

Jennifer A Bohl (JA)

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20892.

Vida Ahyong (V)

Chan Zuckerberg Biohub, San Francisco, CA 94158.

Sophana Chea (S)

International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Liz Fahsbender (L)

Chan Zuckerberg Initiative, Redwood City, CA 94063.

Rekol Huy (R)

National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh 120801, Cambodia.

Sreyngim Lay (S)

International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Rithea Leang (R)

National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh 120801, Cambodia.

Yimei Li (Y)

Department of Ecology and Evolution, University of Chicago, Chicago, IL 60637.

Chanthap Lon (C)

International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Somnang Man (S)

International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.
National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh 120801, Cambodia.

Mengheng Oum (M)

International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Graham R Northrup (GR)

Center for Computational Biology, University of California, Berkeley, CA 94720.

Fabiano Oliveira (F)

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20892.

Andrea R Pacheco (AR)

International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Daniel M Parker (DM)

Department of Population Health and Disease Prevention, University of California, Irvine, CA 92697.
Department of Epidemiology and Biostatistics, University of California, Irvine, CA 92697.

Katherine Young (K)

Department of Biological Sciences, University of Texas, El Paso, TX 79968.

Michael Boots (M)

Department of Integrative Biology, University of California, Berkeley, CA 94720.

Cristina M Tato (CM)

Chan Zuckerberg Biohub, San Francisco, CA 94158.

Joseph L DeRisi (JL)

Chan Zuckerberg Biohub, San Francisco, CA 94158.

Christina Yek (C)

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20892.
International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Jessica E Manning (JE)

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20892.
International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, NIH, Phnom Penh 120801, Cambodia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH